Clinical trial
Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in…
NCT00285675 · Novacea, Industry · Unknown status
Key facts
| NCT number | NCT00285675 |
|---|---|
| Title | Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004 |
| Official title | A Continuation Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004 |
| Lead sponsor | Novacea, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Androgen Independent Prostate Cancer (AIPC), Non Small Cell Lung Cancer (NSCLC) |
| Intervention type | Drug |
| Interventions | DN-101 (calcitriol) - Drug |
| Enrollment | 25 |
| Start date | Apr 1, 2006 |
| Completion | Jan 1, 2008 |
| First posted | Feb 2, 2006 |
| Last update posted | May 31, 2006 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: